Check Amylyx Pharmaceuticals, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.3B
EPS (TTM)
-1.7297
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-0.87
Industry PE ratio
-3.9415151515151514
P/B Ratio
0PEG Ratio
0EBITDA
-196.3M
Revenue (TTM)
-249.0K
Profit Margin
0.00%
Return On Equity TTM
19083400.00%
Track how Amylyx Pharmaceuticals, Inc. P/E has moved over time to understand its valuation trends.
Amylyx Pharmaceuticals, Inc. in the last 5 years
Lowest (21.90x)
December 31, 2023
Industry (-3.94x)
September 18, 2025
Today (-0.87x)
September 18, 2025
Highest (23.35x)
March 31, 2024
Today’s Price to Earnings Ratio: -0.87x
Compare market cap, revenue, PE, and other key metrics of Amylyx Pharmaceuticals, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $1.3B | NA | -0.87 | 0.00% | |
BUY | $60.5B | 241.54% | -505.15 | -12.96% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $99.3B | 45.88% | 27.56 | 31.86% | |
BUY | $60.9B | 5.45% | 14.49 | 31.37% |
The Amylyx Pharmaceuticals, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Amylyx Pharmaceuticals, Inc. investment value today
Current value as on today
₹4,63,981
Returns
₹3,63,981
(+363.98%)
Returns from Amylyx Pharmaceuticals, Inc. Stock
₹3,59,028 (+359.03%)
Dollar Returns*
₹4,953 (+4.95%)
Based on 13 analysts
53.85%
Buy
46.15%
Hold
0.00%
Sell
Based on 13 analysts, 53.85% of analysts recommend a 'BUY' rating for Amylyx Pharmaceuticals, Inc.. Average target price of $14.88
Get share price movements and forecasts by analysts on Amylyx Pharmaceuticals, Inc..
What analysts predicted
11.16%UPSIDE
Target Price
$14.88
Current Price
$13.22
Analyzed by
13 Analysts
Target
$14.88
Amylyx Pharmaceuticals, Inc. target price $14.88, a slight upside of 11.16% compared to current price of $13.22. According to 13 analysts rating.
Search interest for Amylyx Pharmaceuticals, Inc. Stock has increased by 529% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:529% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 1 Year
In the last 1 year, AMLX has outperformed top 5 stocks with highest market-cap in its industry
Price Rise
In the last 7 days, AMLX stock has moved up by 7.9%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 168.0%
Revenue Fall
Revenue is down for the last 2 quarters, 416.0K → -665.0K (in $), with an average decrease of 259.9% per quarter
Profit Down
Netprofit is down for the last 2 quarters, -35.90M → -41.44M (in $), with an average decrease of 15.4% per quarter
Organisation | Amylyx Pharmaceuticals, Inc. |
Headquarters | 43 Thorndike Street, Cambridge, MA, United States, 02141 |
Industry | Services |
CEO | Mr. Joshua B. Cohen |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. James M. Frates M.B.A. | Chief Financial Officer |
Ms. Gina M. Mazzariello J.D. | Chief Legal Officer & General Counsel |
Ms. Lindsey Allen | Head of Investor Relations & Communications |
Ms. Linda A. Arsenault | Chief Human Resources Officer |
Ms. Tammy Sarnelli | Global Head of Regulatory Affairs |
Mr. Joshua B. Cohen | Co-Founder, Co-CEO & Director |
Mr. Justin B. Klee | Co-Founder, Co-CEO & Director |
Dr. Jamie Timmons | Head of Global Medical Strategy & Communications |
Mr. Tom Holmes | Chief Technical Operations Officer |
Dr. Machelle Manuel Ph.D. | VP & Head of Global Medical Affairs |
Amylyx Pharmaceuticals, Inc. share price today is $13.22 as on . Amylyx Pharmaceuticals, Inc. share today touched a day high of $13.33 and a low of $12.62.
Amylyx Pharmaceuticals, Inc. share touched a 52 week high of $13.1 on and a 52 week low of $2.6 on . Amylyx Pharmaceuticals, Inc. stock price today i.e. is trending at $13.22,which is -0.92% down from its 52 week high and 408.46% up from its 52 week low.
Amylyx Pharmaceuticals, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Amylyx Pharmaceuticals, Inc. (AMLX) shares with as little as ₹88.114 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Amylyx Pharmaceuticals, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Amylyx Pharmaceuticals, Inc. share’s latest price of $13.22 as on September 19, 2025 at 12:43 am IST, you will get 0.7564 shares of Amylyx Pharmaceuticals, Inc.. Learn more about
fractional shares .